N-methyl-D-aspartate preconditioning improves short-term motor deficits outcome after mild traumatic brain injury in mice

Journal of Neuroscience Research

Volumn 88, Issue 6, 2010, Pages 1329-1337

  Costa, Tayana ^a   Constantino, Leandra C ^a   Mendonça, Bruna P ^a   Pereira, Josimar G ^a   Herculano, Bruno ^b   Tasca, Carla I ^b   Boeck, Carina R ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Motor behavior; Neuroprotection; NMDA preconditioning; Trauma brain injury

Indexed keywords

ASPARTIC ACID; DNA; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONDITIONING; CONTROLLED STUDY; DNA FOOTPRINTING; DNA FRAGMENTATION; INHALATION ANESTHESIA; LOCOMOTION; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; ROTAROD TEST; SENSORIMOTOR FUNCTION; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; CELL COUNT; CEREBELLUM; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; DYSKINESIAS; MALE; MICE; MOTOR ACTIVITY; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; POSTURAL BALANCE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 77951591978     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22300     Document Type: Article

References (59)

1. Adelson PD, Robichaud P, Hamilton RL, Kochanek PM. 1996. A model of diffuse traumatic brain injury in the immature rat. J Neurosurg 85:877-884. (Pubitemid 26362153)
2. Adelson PD, Dixon CE, Robichaud P, Kochanek PM. 1997. Motor and cognitive functional deficits following diffuse traumatic brain injury in the immature rat. J Neurotrauma 14:99-108. (Pubitemid 27130865)
3. Bernert H, Turski L. 1996. Traumatic brain damage prevented by the non-N-methyl-D-aspartate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f] quinoxaline. Proc Natl Acad Sci U S A 93:5235-5240. (Pubitemid 26159432)
4. Billinger M, Fleisch M, Eberli FR, Garachemani A, Meier B, Seiler C. 1999. Is the development of myocardial tolerance to repeated ischemia in humans due to preconditioning or to collateral recruitment? J Am Coll Cardiol 33:1027-1035.
5. Boeck CR, Ganzella M, Lottermann A, Vendite D. 2004. NMDA pre-conditioning protects against seizures and hippocampal neurotoxicity induced by quinolinic acid in mice. Epilepsia 45:745-750. (Pubitemid 38890971)
6. Boeck CR, Kroth EH, Bronzatto MJ, Vendite D. 2005. Adenosine receptors co-operate with NMDA preconditioning to protect cerebellar granule cells against glutamate neurotoxicity. Neuropharmacology 49: 17-24. (Pubitemid 40910012)
7. Bristow LJ, Flatman KL, Hutson PH, Kulagowski JJ, Leeson PD, Young L, Tricklebank MD. 1996. The atypical neuroleptic profile of the glycine/ N-methyl-D-aspartate receptor antagonist, L-701,324, in rodents. J Pharmacol Exp Ther 277:578-585. (Pubitemid 27168964)
8. Carter RJ, Lione LA, Humby T, Mangiarini L, Mahal A, Bates GP, Dunnett SB, Morton AJ. 1999. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 19:3248-3257. (Pubitemid 29174016)
9. Choi DW. 1988. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634.
10. Chuang DM, Gao XM, Paul SM. 1992. N-methyl-D-aspartate exposure blocks glutamate toxicity in cultured cerebellar granule cells. Mol Pharmacol 42:210-216. (Pubitemid 23026151)
11. Damschroder-Williams P, Irwin RP, Lin SZ, Paul SM. 1995. Characterization of the excitoprotective actions of N-methyl-D-aspartate in cultured cerebellar granule neurons. J Neurochem 65:1069-1076.
12. Dietrich MO, Mantese CE, Anjos G, Souza DO, Farina M. 2005. Motor impairment induced by oral exposure to methylmercury in adult mice. Environ Toxicol Pharmacol 19:169-175. (Pubitemid 39601913)
13. Dunham NW, Miya TS. 1957. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc 46:208-209.
14. Faden AI, Demediuk P, Panter SS, Vink R. 1989. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244:798-800. (Pubitemid 19163864)
15. Farlow MR, Graham SM, Alva G. 2008. Memantine for the treatment of Alzheimer's disease: tolerability and safety data from clinical trials. Drug Saf 31:577-585. (Pubitemid 351861950)
16. Ferguson AL, Stone TW. 2008. Adenosine preconditions against ouabain but not against glutamate on CA1-evoked potentials in rat hippocampal slices. Eur J Neurosci 28:2084-2098.
17. Foda MA, Marmarou A. 1994. A new model of diffuse brain injury in rats. Part II: morphological characterization. J Neurosurg 80:301-313. (Pubitemid 24036502)
18. Fujimoto ST, Longhi L, Saatman KE, Conte V, Stocchetti N, McIntosh TK. 2004. Motor and cognitive function evaluation following experimental traumatic brain injury. Neurosci Biobehav Rev 28:365-378. (Pubitemid 39077928)
19. Giménez-Llort L, Martínez E, FerréS. 1997. Different effects of dopamine antagonists on spontaneous and NMDA-induced motor activity in mice. Pharmacol Biochem Behav 56:549-553.
20. Grabb MC, Choi DW. 1999. Ischemic tolerance in murine cortical cell culture: critical role for NMDA receptors. J Neurosci 19:1657-1662.
21. Grusser-Cornehls U, Baurle J. 2001. Mutant mice as a model for cerebellar ataxia. Prog Neurobiol 63:489-540. (Pubitemid 32115431)
22. Jadhav V, Solaroglu I, Obenaus A, Zhang JH. 2007. Neuroprotection against surgically induced brain injury. Surg Neurol 67:15-20; discussion 20. (Pubitemid 46038501)
23. Jiang X, Zhu D, Okagaki P, Lipsky R, Wu X, Banaudha K, Mearow K, Strauss KI, Marini AM. 2003. N-methyl-D-aspartate and TrkB receptor activation in cerebellar granule cells: an in vitro model of preconditioning to stimulate intrinsic survival pathways in neurons. Ann N Y Acad Sci 993:134-145; discussion 159-160.
24. Jonas W, Lin Y, Tortella F. 2001. Neuroprotection from glutamate toxicity with ultra-low dose glutamate. Neuroreport 12:335-339. (Pubitemid 32114376)
25. Kashluba S, Hanks RA, Casey JE, Millis SR. 2008. Neuropsychologic and functional outcome after complicated mild traumatic brain injury. Arch Phys Med Rehabil 89:904-911. (Pubitemid 351602246)
26. Katz DI, White DK, Alexander MP, Klein RB. 2004. Recovery of ambulation after traumatic brain injury. Arch Phys Med Rehabil 85: 865-869. (Pubitemid 38881012)
27. Kitagawa K, Matsumoto M, Kuwabara K, Tagaya M, Ohtsuki T, Hata R, Ueda H, Handa N, Kimura K, Kamada T. 1991. "Ischemic tolerance" phenomenon detected in various brain regions. Brain Res 561: 203-211.
28. Kuo JR, Lo CJ, Chio CC, Chang CP, Lin MT. 2007. Resuscitation from experimental traumatic brain injury by agmatine therapy. Resuscitation 75:506-514. (Pubitemid 350052367)
29. Lin CH, Chen PS, Gean PW. 2008. Glutamate preconditioning prevents neuronal death induced by combined oxygen-glucose deprivation in cultured cortical neurons. Eur J Pharmacol 589:85-93.
30. Liu Y, Peterson DA, Kimura H, Schubert D. 1997. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem 69:581-593. (Pubitemid 27327958)
31. Marini AM, Paul SM. 1992. N-methyl-D-aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis. Proc Natl Acad Sci U S A 89:6555-6559.
32. Marini AM, Rabin SJ, Lipsky RH, Mocchetti I. 1998. Activity-dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-methyl-D-aspartate. J Biol Chem 273:29394-29399. (Pubitemid 28509940)
33. Miller LP, Lyeth BG, Jenkins LW, Oleniak L, Panchision D, Hamm RJ, Phillips LL, Dixon CE, Clifton GL, Hayes RL. 1990. Excitatory amino acid receptor subtype binding following traumatic brain injury. Brain Res 526:103-107. (Pubitemid 20273567)
34. Milman A, Rosenberg A, Weizman R, Pick CG. 2005. Mild traumatic brain injury induces persistent cognitive deficits and behavioral disturbances in mice. J Neurotrauma 22:1003-1010. (Pubitemid 41362066)
35. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63. (Pubitemid 14203433)
36. Muir KW. 2006. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. Curr Opin Pharmacol 6:53-60.
37. Muir KW, Lees KR. 1995. Clinical experience with excitatory amino acid antagonist drugs. Stroke 26:503-513.
38. Ogita K, Okuda H, Yamamoto Y, Nishiyama N, Yoneda Y. 2003. In vivo neuroprotective role of NMDA receptors against kainate-induced excitotoxicity in murine hippocampal pyramidal neurons. J Neurochem 85:1336-1346.
39. Pagliaro P, Gattullo D, Rastaldo R, Losano G. 2001. Ischemic preconditioning: from the first to the second window of protection. Life Sci 69: 1-15. (Pubitemid 32536730)
40. Piot-Grosjean O, Wahl F, Gobbo O, Stutzmann JM. 2001. Assessment of sensorimotor and cognitive deficits induced by a moderate traumatic injury in the right parietal cortex of the rat. Neurobiol Dis 8:1082-1093. (Pubitemid 34017101)
41. Pohl D, Bittigau P, Ishimaru MJ, Stadthaus D, Hubner C, Olney JW, Turski L, Ikonomidou C. 1999. N-methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc Natl Acad Sci U S A 96:2508-2513. (Pubitemid 29117946)
42. Raghupathi R. 2004. Cell death mechanisms following traumatic brain injury. Brain Pathol 14:215-222. (Pubitemid 38656395)
43. Rejdak R, Rejdak K, Sieklucka-Dziuba M, Stelmasiak Z, Grieb P. 2001. Brain tolerance and preconditioning. Pol J Pharmacol 53:73-79.
44. Roche KW, Standley S, McCallum J, Dune Ly C, Ehlers MD, Wenthold RJ. 2001. Molecular determinants of NMDA receptor internalization. Nat Neurosci 4:794-802. (Pubitemid 32702511)
45. Rybnikova E, Vataeva L, Tyulkova E, Gluschenko T, Otellin V, Pelto-Huikko M, Samoilov MO. 2005. Mild hypoxia preconditioning prevents impairment of passive avoidance learning and suppression of brain NGFI-A expression induced by severe hypoxia. Behav Brain Res 160: 107-114. (Pubitemid 40504160)
46. Saatman KE, Duhaime AC, Bullock R, Maas AI, Valadka A, Manley GT. 2008. Classification of traumatic brain injury for targeted therapies. J Neurotrauma 25:719-738.
47. Saleh MC, Connell BJ, Saleh TM. 2009. Ischemic tolerance following low dose NMDA involves modulation of cellular stress proteins. Brain Res 1247:212-220.
48. Sasahira M, Lowry T, Simon RP, Greenberg DA. 1995. Epileptic tolerance: prior seizures protect against seizure-induced neuronal injury. Neurosci Lett 185:95-98.
49. Schumann J, Alexandrovich GA, Biegon A, Yaka R. 2008. Inhibition of NR2B phosphorylation restores alterations in NMDA receptor expression and improves functional recovery following traumatic brain injury in mice. J Neurotrauma 25:945-957.
50. Sei Y, Fossom L, Goping G, Skolnick P, Basile AS. 1998. Quinolinic acid protects rat cerebellar granule cells from glutamate-induced apoptosis. Neurosci Lett 241:180-184. (Pubitemid 28114191)
51. Shein NA, Horowitz M, Shohami E. 2007. Heat acclimation: a unique model of physiologically mediated global preconditioning against traumatic brain injury. Prog Brain Res 161:353-363. (Pubitemid 47017415)
52. Soriano FX, Papadia S, Hofmann F, Hardingham NR, Bading H, Hardingham GE. 2006. Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability. J Neurosci 26:4509-4518. (Pubitemid 44315350)
53. Tauskela JS, Brunette E, Monette R, Comas T, Morley P. 2003. Preconditioning of cortical neurons by oxygen-glucose deprivation: tolerance induction through abbreviated neurotoxic signaling. Am J Physiol Cell Physiol 285:C899-C911. (Pubitemid 37158815)
54. Ucar T, Tanriover G, Gurer I, Onal MZ, Kazan S. 2006. Modified experimental mild traumatic brain injury model. J Trauma 60:558-565.
55. Vandresen-Filho S, de Araujo Herculano B, Franco JL, Boeck CR, Dafre AL, Tasca CI. 2007. Evaluation of glutathione metabolism in NMDA preconditioning against quinolinic acid-induced seizures in mice cerebral cortex and hippocampus. Brain Res 1184:38-45. (Pubitemid 350160596)
56. Vohra HA, Galinanes M. 2006. Myocardial preconditioning against ischemia-induced apoptosis and necrosis in man. J Surg Res 134:138-144. (Pubitemid 43866819)
57. Willis C, Lybrand S, Bellamy N. 2004. Excitatory amino acid inhibitors for traumatic brain injury. Cochrane Database Syst Rev CD003986.
58. Wong J, Hoe NW, Zhiwei F, Ng I. 2005. Apoptosis and traumatic brain injury. Neurocrit Care 3:177-182.
59. Yang GM, Paul SM. 1997. Cultured cerebellar granule neurons as a model of neuronal apoptosis. In: Poirier J, editor. Neuromethods. Totowa, NJ: Humana Press. p 47-66.